Search for Clinical Trial Results
Bullous Pemphigoid - 27 Studies Found
Status | Study |
Terminated |
Study Name: Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid Condition: Bullous Pemphigoid Date: 2012-04-04 Interventions: Drug: DF2156A DF2156A is a novel small molecule that inhibits the biological activity of the CXC ligand |
Recruiting |
Study Name: Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid Condition: Bullous Pemphigoid Date: 2016-06-24 Interventions:
|
Not yet recruiting |
Study Name: Ixekizumab in the Treatment of Bullous Pemphigoid Condition:
Date: 2017-03-21 Interventions: Drug: Ixekizumab Subcutaneous injection Other Name: |
Recruiting |
Study Name: Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid Condition: Bullous Pemphigoid Date: 2016-08-11 Interventions: Other: Blood sample and cotton skin swabs |
Completed |
Study Name: Anti-IL-5 Therapy in Bullous Pemphigoid (BP) Condition: Pemphigoid, Bullous Date: 2012-10-05 Interventions:
|
Completed |
Study Name: Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission Condition:
Date: 2010-12-21 |
Recruiting |
Study Name: Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid Condition: Pemphigoid, Bullous Date: 2014-07-27 Interventions: Biological: Bertilimumab |
Recruiting |
Study Name: Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid Condition: Bullous Pemphigoid Date: 2015-01-07 Interventions:
|
Completed |
Study Name: Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid Condition: Ocular Cicatricial Pemphigoid Date: 2007-12-26 Interventions: Drug: Rituximab The Rituximab dose is 1000mg (1gm) given as an IV infusion every two weeks for 2 doses ( |
Recruiting |
Study Name: Pruritus and Pemphigoid in Nursing Home Patients Condition:
Date: 2016-06-28 Interventions: Other: Blood sample One extra blood sample of 10 ml will be taken during a routine venapunction for immu |